JNJ

Johnson & Johnson
NYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL

Key Statistics

Market Cap
$539.70B
P/E Ratio
26.31
EPS
$8.52
Beta
0.26
52W High
$251.71
52W Low
$142.16
50-Day MA
$238.15
200-Day MA
$206.58
Dividend Yield
2.29%
Profit Margin
21.80%
Forward P/E
19.65
PEG Ratio
2.95

About Johnson & Johnson

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$96.36B
Gross Profit (TTM)$65.56B
EBITDA$34.33B
Operating Margin27.40%
Return on Equity26.40%
Return on Assets8.42%
Revenue/Share (TTM)$40.02
Book Value$33.73
Price-to-Book6.74
Price-to-Sales (TTM)5.60
EV/Revenue6.02
EV/EBITDA17.20
Quarterly Earnings Growth (YoY)-52.90%
Quarterly Revenue Growth (YoY)9.90%
Shares Outstanding$2.41B
Float$2.40B
% Insiders0.06%
% Institutions76.21%

Historical Volatility

HV 10-Day
20.77%
HV 20-Day
17.90%
HV 30-Day
16.79%
HV 60-Day
16.37%
HV Rank
61.5%

Volatility is currently expanding

Analyst Ratings

Consensus ($252.42 target)
5
Strong Buy
9
Buy
10
Hold
1
Strong Sell

More HEALTHCARE Stocks

Data last updated: 5/5/2026